Target intelligence / Profile preview

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lipid envelope (SARS-CoV-2 lipid envelope)

Target
SARS-CoV-2 lipid envelope
Molecular classification
Other
01

Overview

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lipid envelope is a host-derived membrane that encapsulates the viral genome and nucleocapsid, playing a vital role in the virus's life cycle (Source: Nature Reviews Microbiology, 2020). It is primarily composed of phospholipids and cholesterol acquired from the host's endoplasmic reticulum-Golgi intermediate compartment during the budding process (Source: Journal of Biological Chemistry, 2021). This envelope acts as a structural scaffold for the Spike (S), Membrane (M), and Envelope (E) proteins, which are essential for host cell recognition and entry (Source: Cell, 2020). Because the integrity of this lipid bilayer is required for the virus to fuse with host cell membranes, it represents a critical vulnerability for inactivation (Source: Lancet Microbe, 2020). Disruption of the envelope by surfactants, detergents, or organic solvents like ethanol leads to the immediate loss of viral infectivity (Source: CDC, 2022). Consequently, the lipid envelope is the primary target for most environmental disinfectants and antiseptic mouthwashes or nasal sprays designed to reduce viral transmission (Source: Journal of Hospital Infection, 2020). While it is a robust target for external inactivation, the lack of specificity compared to viral proteins poses significant challenges for developing systemic therapeutic agents (Source: Trends in Pharmacological Sciences, 2021). Research continues into lipid-modulating compounds that might interfere with the envelope's formation or stability during the viral replication cycle (Source: Frontiers in Microbiology, 2021).

Other names
SARS-CoV-2 viral envelopeSARS-CoV-2 membraneCoronavirus lipid bilayer
02

Mechanism of action

The primary mechanism involves the solubilization and disruption of the lipid bilayer by amphiphilic molecules or organic solvents, which leads to the denaturation of embedded proteins and the loss of the virus's ability to fuse with host cell membranes (Source: Journal of Hospital Infection, 2020; CDC, 2022).

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Non-specific membrane disruptionCytotoxicity to host cellsMucosal irritationSystemic toxicity
06

Interacting drugs

Ethanol

5 more in the full profile.

07

Biomarkers

Viral RNA loadSARS-CoV-2 antigen levels

Beyond the preview

Go deeper on Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lipid envelope (SARS-CoV-2 lipid envelope).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lipid envelope (SARS-CoV-2 lipid envelope).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call